GeoVax Labs is one of the biotech companies that do not participate in the race for COVID-19 vaccine development. However, other infectious and oncological diseases make the company busier than ever. Due to developing vaccines against them make GeoVax Labs’ stock soar as investors see the future potential for effective treatment.
For instance, today OTC: GOVX surges 62% by increasing daily volume to 2.4 million shares. Due to filing for an equity offering GeoVax Labs manages to lift demand for its penny stock.
Before GOVX rises above $2 current stockholders might hold newly bought shares for a while to make quick profits with little funds invested.
Editor in Chief.
Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life